Mullerian and Mesothelial Lymph Node Involvement in Patients with Borderline Ovarian Tumors

被引:0
作者
Eltabbakh, Gamal H. [1 ]
Mount, Sharon L.
机构
[1] Lake Champlain Gynecol Oncol, PC, S Burlington, VT 05403 USA
关键词
lymph nodes; mixed tumor; Mullerian; neoplasms; mesothelial; ovarian tumor; SEROUS TUMORS; INCLUSION CYSTS; METASTASES; ACCURACY; IMMUNOHISTOCHEMISTRY; ADENOCARCINOMA; CALRETININ; CARCINOMA; DIAGNOSIS; ORIGIN;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To determine the true incidence of Mullerian and mesothelial lymph node involvement in serous and mucinous borderline ovarian tumors (BLOT) with serial sectioning and immunohistochemistry. STUDY DESIGN: Formalin-fixed, paraffin-embedded lymph node blocks from patients with serous (N = 21) and mucinous (N = 5) BLOT who underwent lymphadenectomy between 1995 and 2002 were serially sectioned at 5 14 levels with 3 consecutive sections taken at surface, 125 mu and 475 mu. One slide from each level was stained with hematoxylin-eosin (H-E), cytokeratin (AE1-AE3, DAKO) and calretinin (DAKO). Lymph node involvement was defined as epithelioid cells recognized by H-E and confirmed by immunoreaction with keratin (Mullerian) and calretinin (mesothelial) or identified by immunohistochemistry alone. The results obtained by serial sectioning and immunohistochemistry were compared with those obtained by routine histologic examination at the time of the original surgery. RESULTS: A total of 240 lymph nodes (215 from patients with serous and 25 from patients with mucinous BLOT) were examined. Original pathologic examination identified lymph node involvement in 29/215 lymph nodes from 21 patients with serous BLOT. Twelve of the 21 patients with serous BLOT (57%) and none of the 5 patients with mucinous BLOT (0%) demonstrated Mullerian lymph node involvement. Serial sectioning and keratin immunostaining identified Mullerian involvement in 4 (1.6%) and 10 (4.2%) additional nodes not diagnosed in original sections, respectively. However, no additional node-positive patients were identified. Mesothelial involvement was identified in 2 patients (2/26, 7.6%). CONCLUSION: Patients with serous BLOT have a high incidence of Mullerian lymph node involvement. Distinction between Mullerian and mesothelial differentiation may require immunohistochemical study. Compared with routine histologic examination, serial sectioning and immunohistochemical examination yield a higher number of involved lymph nodes. (J Reprod Med 2011;56:211-218)
引用
收藏
页码:211 / 218
页数:8
相关论文
共 50 条
  • [1] Prognostic value of lymph node involvement in ovarian serous borderline tumors
    Lesieur, Benedicte
    Kane, Aminata
    Duvillard, Pierre
    Gouy, Sebastien
    Pautier, Patricia
    Lhomme, Catherine
    Morice, Philippe
    Uzan, Catherine
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 (05) : 438.e1 - 438.e7
  • [2] Recent Developments on the Significance and Pathogenesis of Lymph Node Involvement in Ovarian Serous Tumors of Low Malignant Potential (Borderline Tumors)
    Fadare, Oluwole
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (01) : 103 - 108
  • [3] Complete lymph node dissection: is it essential for the treatment of borderline epithelial ovarian tumors?
    Kanat-Pektas, Mine
    Ozat, Mustafa
    Gungor, Tayfun
    Sahin, Izzet
    Yalcin, Hakan
    Ozdal, Bulent
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2011, 283 (04) : 879 - 884
  • [4] Predicting Lymph Node Involvement in Borderline Ovarian Tumors with a Quantitative Model and Nomogram: A Retrospective Cohort Study
    Zhang, Menglei
    Zhou, Fangyue
    He, Yuan
    Tao, Xiang
    Hua, Keqin
    Ding, Jingxin
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 1529 - 1539
  • [5] Lymph Node Involvement in Recurrent Serous Borderline Ovarian Tumors: Current Evidence, Controversies, and a Review of the Literature
    Wetterwald, Laureline
    Sarivalasis, Apostolos
    Liapi, Aikaterini
    Mathevet, Patrice
    Achtari, Chahin
    CANCERS, 2023, 15 (03)
  • [6] Influence of lymph node involvement or lymphadenectomy on prognosis of patients with borderline ovarian tumors: A systematic review and meta-analysis
    Fan, Yu
    Zhang, Yu-fei
    Wang, Meng-yao
    Mu, Yi
    Mo, Si-ping
    Li, Jin-ke
    GYNECOLOGIC ONCOLOGY, 2021, 162 (03) : 797 - 803
  • [7] Significance of lymph node ratio on survival of women with borderline ovarian tumors
    Nusbaum, David J.
    Mandelbaum, Rachel S.
    Machida, Hiroko
    Matsuzaki, Shinya
    Roman, Lynda D.
    Sood, Anil K.
    Gershenson, David M.
    Matsuo, Koji
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2020, 301 (05) : 1289 - 1298
  • [8] OVARIAN SEROUS BORDERLINE TUMORS WITH LYMPH-NODE INVOLVEMENT - CLINICOPATHOLOGICAL AND DNA CONTENT STUDY OF 7 CASES AND REVIEW OF THE LITERATURE
    TAN, LK
    FLYNN, SD
    CARCANGIU, ML
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1994, 18 (09) : 904 - 912
  • [9] Lymph Node Involvement in Ovarian Serous Tumors of Low Malignant Potential: A Clinicopathologic Study of Thirty-six Cases
    Djordjevic, Bojana
    Malpica, Anais
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2010, 34 (01) : 1 - 9
  • [10] IMMUNOHISTOCHEMICAL CHARACTERIZATION OF OVARIAN BORDERLINE TUMORS OF INTESTINAL AND MULLERIAN TYPES
    RUTGERS, JL
    BELL, DA
    MODERN PATHOLOGY, 1992, 5 (04) : 367 - 371